SUSQUEHANNA INTERNATIONAL GROUP, LLP - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 75 filers reported holding ACCELERATE DIAGNOSTICS INC in Q2 2022. The put-call ratio across all filers is 27.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q4 2022$164,752
-88.0%
232,621
-74.2%
0.00%
Q3 2022$1,369,000
+319.9%
900,726
+173.9%
0.00%
Q2 2022$326,000
-5.2%
328,877
+37.6%
0.00%
Q1 2022$344,000
-90.2%
239,028
-64.4%
0.00%
Q4 2021$3,500,000
+109.6%
670,778
+134.1%
0.00%
Q3 2021$1,670,000
-40.7%
286,485
-18.0%
0.00%
Q2 2021$2,817,000
-0.9%
349,582
+2.3%
0.00%
Q1 2021$2,844,000
-10.5%
341,882
-18.4%
0.00%
Q4 2020$3,178,000
+24.8%
419,060
+75.4%
0.00%
Q3 2020$2,546,000
-68.5%
238,932
-55.2%
0.00%
-100.0%
Q2 2020$8,082,000
+138.6%
533,090
+31.1%
0.00%
Q1 2020$3,387,000
-74.2%
406,671
-47.6%
0.00%
-100.0%
Q4 2019$13,124,000
+3.4%
776,513
+13.6%
0.01%0.0%
Q3 2019$12,696,000
-68.0%
683,702
-60.6%
0.01%0.0%
Q2 2019$39,736,000
+227.9%
1,736,695
+201.2%
0.01%
+25.0%
Q1 2019$12,120,000
+39.5%
576,571
-23.7%
0.00%
+33.3%
Q4 2018$8,687,000
-54.6%
755,345
-9.5%
0.00%
-57.1%
Q3 2018$19,149,000
+71.4%
834,394
+66.5%
0.01%
+75.0%
Q2 2018$11,174,000
-4.7%
501,076
-2.4%
0.00%0.0%
Q1 2018$11,731,000
+12.9%
513,388
+29.4%
0.00%
+33.3%
Q4 2017$10,393,000
-9.1%
396,700
-22.1%
0.00%
-25.0%
Q3 2017$11,437,000
-15.4%
509,433
+3.1%
0.00%
-33.3%
Q2 2017$13,515,000
+111.6%
494,140
+87.2%
0.01%
+50.0%
Q1 2017$6,388,000
+6.7%
263,957
-8.5%
0.00%
+33.3%
Q4 2016$5,985,000
-3.8%
288,465
+26.4%
0.00%0.0%
Q3 2016$6,222,000
+243.0%
228,248
+81.0%
0.00%
+200.0%
Q2 2016$1,814,000
+15.3%
126,074
+15.2%
0.00%
Q1 2016$1,573,000
-27.1%
109,473
+9.0%
0.00%
Q4 2015$2,157,000
+28.2%
100,397
-3.5%
0.00%
Q3 2015$1,683,000
+9.0%
104,034
+76.7%
0.00%
Q2 2015$1,544,000
-53.7%
58,887
-60.3%
0.00%
-100.0%
Q1 2015$3,337,000
+153.6%
148,275
+116.1%
0.00%
Q4 2014$1,316,000
-56.8%
68,609
-51.6%
0.00%
-100.0%
Q3 2014$3,048,000
-47.0%
141,898
-35.9%
0.00%
-50.0%
Q2 2014$5,755,000
+121.7%
221,344
+86.0%
0.00%
+100.0%
Q1 2014$2,596,000
+192.7%
119,000
+63.6%
0.00%
Q4 2013$887,00072,7410.00%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Birchview Capital, LP 2,213,326$18,386,00010.92%
ORACLE INVESTMENT MANAGEMENT INC 3,776,121$31,417,0004.70%
GRIFFIN ASSET MANAGEMENT, INC. 1,358,644$11,304,0001.44%
Selkirk Management LLC 288,805$2,403,0000.72%
Chicago Capital, LLC 1,593,126$13,255,0000.56%
Cannell & Co. 1,097,419$9,131,0000.29%
TCI Wealth Advisors, Inc. 55,586$462,0000.20%
Belpointe Asset Management LLC 197,853$1,646,0000.14%
ALGERT GLOBAL LLC 29,580$246,0000.08%
THOMPSON INVESTMENT MANAGEMENT, INC. 60,900$507,0000.08%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders